12:00 AM
 | 
Sep 21, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Fab-001: Phase I started

FAB began a Phase I trial to evaluate single injections of Fab-001 in healthy volunteers.

FAB Pharma...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >